AstraZeneca Covid vax linked to another rare fatal blood clotting disorder

New Delhi: British-Swedish pharma giant AstraZeneca’s Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) — a rare but fatal blood clotting disorder, claimed researchers on Thursday.

While not new, VITT emerged as a new disease following adenovirus vector-based Oxford-AstraZeneca vaccine — sold as Covishield in India and Vaxzevria in Europe — at the height of the Covid pandemic in 2021.

“An unusually dangerous blood autoantibody directed against a protein termed platelet factor 4 (or PF4)” was found as the reason for VITT.

In separate research in 2023, scientists from Canada, North America, Germany and Italy described a virtually identical disorder with the same PF4 antibody that was fatal in some cases after natural adenovirus (common cold) infection.

Now in a new research, Flinders University in Australia and other international experts found that the PF4 antibodies in both adenovirus infection-associated VITT and classic adenoviral vector VITT share identical molecular fingerprints or signatures.

“Indeed, the pathways of lethal antibody production in these disorders must be virtually identical and have similar genetic risk factors,” said Professor Tom Gordon from Flinders

The researcher noted that the “findings have the important clinical implication that lessons learned from VITT are applicable to rare cases of blood clotting after adenovirus (a common cold) infections, as well as having implications for vaccine development”.

The same team had in a 2022 study “cracked the molecular code of the PF4 antibody and identified a genetic risk factor”.

Their new findings, published in the New England Journal of Medicine, also have important implications for improving vaccine safety.

The research comes after AstraZeneca “accepted, in a legal document submitted to the High Court in February, that its Covid vaccine ‘can, in very rare cases, cause Thrombotic Thrombocytopenic Syndrome (TTS)’.”

TTS is a rare side effect that can cause people to have blood clots and a low blood platelet count. It has been linked to the death of at least 81 people in the UK as well as hundreds of serious injuries.

The company has also voluntarily withdrawn “marketing authorisation” of its Covid vaccine from Europe and other global markets.

IANS

India accounts for 26 pc of global TB burden, the highest: WHO

New Delhi: Even as India aims to end tuberculosis (TB) by 2025, five years ahead of the global target, a report published by the World Health Organization (WHO) on Tuesday...

Govt to slash MRP of 3 anti-cancer drugs after exemption in customs duty, GST rate cut

New Delhi: After custom duty exemption and a reduction in GST rates, the National Pharmaceutical Pricing Authority (NPPA) has now directed the drug manufacturers to reduce the MRP on three...

Illnesses linked to McDonald’s E. coli outbreak rise to 75: CDC

Los Angeles: With more cases being reported, the US Centers for Disease Control and Prevention (CDC) has confirmed that at least 75 people in the country have been sickened by...

Demand for Jan Aushadhi Kendras increases as people get good quality medicines at cheaper rates

New Delhi: The demand for opening more Pradhan Mantri Jan Aushadhi Kendras across the country is increasing as more and more people avail of the cheap generic drugs available at...

Delaying knee arthritis treatment can damage spine, warn health experts

New Delhi: Delay in proper knee treatment, timely detection and ignoring knee arthritis symptoms can worsen the condition of knees and additionally damage the spine affecting the quality of life,...

Rising cardiac arrest, a sign for young India to focus on right approach to life

New Delhi: Cases of cardiac arrest have seen a spurt in recent times, but the bigger question is the ability to diagnose and prevent such cases. The surge in rising...

Union Health Ministry releases new guidelines for non-alcoholic fatty liver disease

New Delhi: The Union Health Ministry on Friday released the revised operational guidelines and training module for non-alcoholic fatty liver disease (NAFLD) -- which affects about three in 10 people....

Packaged juices harmful, no matter ‘healthy’ branding, warn experts

New Delhi: Packaged juices, even the ones that come with the label “healthy”, are dangerous for health, and are low in nutritional value, warned experts on Tuesday, stressing the need...

Over 200 fall ill after drinking contaminated water in Greater Noida

New Delhi: Over 200 residents of a society in Greater Noida fell ill after allegedly consuming contaminated water. The incident came to light on Monday when numerous residents of the...

Maintain ideal heart rate key for better heart health, say doctors

New Delhi: Heart problems are a worldwide plague but maintaining an ideal heart rate may be key in preventing cardiovascular diseases (CVDs) which account for 17.9 million deaths annually, doctors...

Head and neck cancers on the rise in India, youth at key risk: Experts

New Delhi: India is witnessing a significant increase in the incidence of head and neck cancers, with projections estimating 2.1 million new cancer cases by 2040, healthcare experts said on...

What is viral hepatitis and how is it affecting people?

New Delhi: Contaminated food and water are increasing cases of hepatitis in the country, said experts on World Hepatitis Day, on Sunday. World Hepatitis Day is observed every year on...

Read Previous

Covaxin shows excellent safety track record: Bharat Biotech on study citing risks

Read Next

Sensex rises 155 points after positive global cues

WP2Social Auto Publish Powered By : XYZScripts.com